Literature DB >> 16247563

The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Michael T Compton1, Paul S Weiss, Joyce C West, Nadine J Kaslow.   

Abstract

BACKGROUND: Substance abuse among individuals with schizophrenia-spectrum disorders (SSDs) is associated with a range of adverse psychosocial outcomes in the areas of occupational functioning, housing stability, economic independence, access to health care, and involvement with the legal system. The aim of this study was to estimate the effects of substance use disorders (SUDs), SSDS, and dual diagnosis with both disorders on the risk for six important Axis IV psychosocial problems. This was accomplished using a large dataset of patients who are representative of individuals in routine US psychiatric practice.
METHOD: Weighted data from the 1999 Study of Psychiatric Patients and Treatments from a practice-based research network of the American Psychiatric Institute for Research and Education were analyzed. Some 615 US psychiatrists provided detailed clinical, psychosocial, and health services information on 1,843 patients, including 285 patients with one or more SUDs without an SSD, 180 patients with a diagnosis of an SSD without substance abuse comorbidity, and 68 dually diagnosed patients. Logistic regression models were used to determine effect estimates (adjusted odds ratios), and corresponding 95% confidence intervals were calculated.
RESULTS: After adjusting for sociodemographic variables and for SSD diagnosis, SUD diagnosis was independently associated with increased risk for five of the Axis IV psychosocial problems of interest (occupational problems, housing problems, economic problems, problems with access to health care services, and problems related to interaction with the legal system/crime) when compared to all other psychiatric patients (n=1,310). After adjusting for the sociodemographic variables and for SUD diagnosis, SSD diagnosis (compared to all other psychiatric diagnoses) was associated with Axis IV economic problems, but not with the other five psychosocial problems of interest. The presence of both an SUD and an SSD diagnosis (dual diagnosis) was associated with a greater risk for four of the six Axis IV psychosocial problems studied, compared to the risks associated with either diagnosis alone. Limiting the substance of abuse to alcohol resulted in similar findings.
CONCLUSIONS: Although SUDs are associated with increased risk for poor social adjustment, the comorbidity of SUDs and SSDs is associated with greatly compounded psychosocial burdens. These findings, from a large sample of representative US psychiatric patients, demonstrate the ongoing need for improved services and policies for those specially burdened patients with the dual diagnosis of both an SSD and substance abuse or dependence.

Entities:  

Mesh:

Year:  2005        PMID: 16247563     DOI: 10.1007/s00127-005-0964-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  20 in total

Review 1.  Psychosocial approaches to dual diagnosis.

Authors:  R E Drake; K T Mueser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

Review 2.  Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.

Authors:  E Cantor-Graae; L G Nordström; T F McNeil
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

3.  Integrating services for schizophrenia and substance abuse.

Authors:  D J Hellerstein; R N Rosenthal; C R Miner
Journal:  Psychiatr Q       Date:  2001

4.  Double jeopardy: schizophrenia and substance use.

Authors:  C D Swofford; G Scheller-Gilkey; A H Miller; B Woolwine; R Mance
Journal:  Am J Drug Alcohol Abuse       Date:  2000-08       Impact factor: 3.829

Review 5.  Substance misuse in patients with schizophrenia: epidemiology and management.

Authors:  David J Kavanagh; John McGrath; John B Saunders; Glenys Dore; Dianne Clark
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Barriers to the care of persons with dual diagnoses: organizational and financing issues.

Authors:  M S Ridgely; H H Goldman; M Willenbring
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

7.  Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort.

Authors:  P Räsänen; J Tiihonen; M Isohanni; P Rantakallio; J Lehtonen; J Moring
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

Review 8.  Substance abuse and schizophrenia: impediments to optimal care.

Authors:  I M Salloum; H B Moss; D C Daley
Journal:  Am J Drug Alcohol Abuse       Date:  1991-09       Impact factor: 3.829

9.  A longitudinal study of substance use and community violence in schizophrenia.

Authors:  B J Cuffel; M Shumway; T L Chouljian; T MacDonald
Journal:  J Nerv Ment Dis       Date:  1994-12       Impact factor: 2.254

10.  Long-term course of substance use disorders among patients with severe mental illness.

Authors:  S J Bartels; R E Drake; M A Wallach
Journal:  Psychiatr Serv       Date:  1995-03       Impact factor: 3.084

View more
  17 in total

1.  Physical wellness and employment status among adults with serious mental illness.

Authors:  Richard W Goldberg; Ann Hackman; Deborah R Medoff; Clayton Brown; Li Juan Fang; Faith Dickerson; Julie Kreyenbuhl; Lisa Dixon
Journal:  Community Ment Health J       Date:  2008-03-18

2.  Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jean Caron
Journal:  Psychiatr Q       Date:  2015-09

3.  The Psychiatric Morbidity of Women Who Give Birth to Children with Fetal Alcohol Spectrum Disorder (FASD): Results of the Manitoba Mothers and FASD Study.

Authors:  Deepa Singal; Marni Brownell; Dan Chateau; Ana Hanlon-Dearman; Sally Longstaffe; Leslie L Roos
Journal:  Can J Psychiatry       Date:  2017-05-26       Impact factor: 4.356

4.  Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia.

Authors:  Luba Leontieva; Jacqueline Dimmock; Michelle Cavallerano; Sara DeRycke; Zsuzsa Meszaros; Kate Carey; Robert Ploutz-Snyder; Steven L Batki
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 5.  Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders.

Authors:  Molly K Larson; Elaine F Walker; Michael T Compton
Journal:  Expert Rev Neurother       Date:  2010-08       Impact factor: 4.618

6.  HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.

Authors:  Geetanjali Chander; Seth Himelhoch; John A Fleishman; James Hellinger; Paul Gaist; Richard D Moore; Kelly A Gebo
Journal:  AIDS Care       Date:  2009-05

7.  Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment.

Authors:  Stephen Magura; Andrew Rosenblum; Thomas Betzler
Journal:  Subst Abuse       Date:  2009-10-28

8.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

9.  Factors associated with substance use problem among Maryland Medicaid enrollees affected by serious mental illness.

Authors:  Krista Schladweiler; Pierre K Alexandre; Donald M Steinwachs
Journal:  Addict Behav       Date:  2009-05-20       Impact factor: 3.913

10.  Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia.

Authors:  Henk Temmingh; Ezra Susser; Sumaya Mall; Megan Campbell; Goodman Sibeko; Dan J Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.